STILDEP: Zolpidem in Depressive and Dysthimic Patients
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
Primary objective: To show that the combination of Zolpidem + antidepressant therapy is more
effective in the treatment of the secondary insomnia of depressive and dysthimic patients
than antidepressant therapy alone in the acute phase of the disease.